Showing results (1021-1030 of 1,077) with videos related to

Sort By:
Pageof 108
Circulation|February 24, 2006
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stentsPramod K Kuchulakanti, William W Chu, Rebecca Torguson, et al.
Neurology|October 24, 2014
Determinants of antithrombotic choice for patent foramen ovale in cryptogenic strokeDavid E Thaler, Robin Ruthazer, Christian Weimar, et al.
The American Journal of Cardiology|February 24, 2009
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stentsMichael A Gaglia, Daniel H Steinberg, Tina L Pinto Slottow, et al.
Nature Cardiovascular Research|June 7, 2024
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular riskRozalina G McCoy, Jeph Herrin, Kavya Sindhu Swarna, et al.
The American Journal of Cardiology|October 24, 2006
Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysisSang-Wook Kim, Gary S Mintz, Patrick Ohlmann, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2010
Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?Asmir I Syed, Amit Kakkar, Amit Karkar, et al.
JACC. Cardiovascular Interventions|November 20, 2010
Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patientsItsik Ben-Dor, Augusto D Pichard, Lowell F Satler, et al.
The American Journal of Cardiology|March 10, 2010
Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacementItsik Ben-Dor, Augusto D Pichard, Lowell F Satler, et al.
The American Journal of Cardiology|July 8, 2008
Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectorisDaniel H Steinberg, Palak Shah, Tim Kinnaird, et al.
Annals of Internal Medicine|November 12, 2019
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and ElaborationDavid M Kent, David van Klaveren, Jessica K Paulus, et al.
Pageof 108